当前位置:首页 - 行情中心 - 宏源药业(301246) - 财务分析 - 现金流量表

宏源药业

(301246)

  

流通市值:23.30亿  总市值:58.24亿
流通股本:1.60亿   总股本:4.00亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金487,934,049.15200,764,860.341,121,247,787.84722,276,237.19
  收到的税费返还18,370,220.758,076,146.8439,963,876.332,619,289.27
  收到其他与经营活动有关的现金18,249,538.4915,361,355.9225,857,835.0917,443,152.41
  经营活动现金流入小计524,553,808.39224,202,363.11,187,069,499.23772,338,678.87
  购买商品、接受劳务支付的现金517,968,616.37261,949,204.31924,940,600.79580,810,525.35
  支付给职工以及为职工支付的现金111,522,550.5463,238,102.75199,171,725.44147,739,847.97
  支付的各项税费22,688,800.188,088,610.0820,816,074.9916,985,837.49
  支付其他与经营活动有关的现金41,888,389.814,514,452.857,950,788.9335,841,672.91
  经营活动现金流出小计694,068,356.89347,790,369.941,202,879,190.15781,377,883.72
  经营活动产生的现金流量净额-169,514,548.5-123,588,006.84-15,809,690.92-9,039,204.85
二、投资活动产生的现金流量:
  收回投资收到的现金2,621,620,299.07534,024,567.944,157,547,636.13,347,000,000
  取得投资收益收到的现金--61,500,00084,071,034.15
  处置固定资产、无形资产和其他长期资产收回的现金净额186,187.6258,294.691,363,421.0894,503.36
  投资活动现金流入小计2,621,806,486.69534,082,862.634,220,411,057.183,431,165,537.51
  购建固定资产、无形资产和其他长期资产支付的现金56,645,483.64,133,615.9160,196,638.68148,971,703.78
  投资支付的现金2,907,300,000811,500,0003,643,500,0002,628,150,000
  取得子公司及其他营业单位支付的现金--3,203,429.6-
  投资活动现金流出小计2,963,945,483.6815,633,615.93,806,900,068.282,777,121,703.78
  投资活动产生的现金流量净额-342,138,996.91-281,550,753.27413,510,988.9654,043,833.73
三、筹资活动产生的现金流量:
  吸收投资收到的现金--470,000-
  其中:子公司吸收少数股东投资收到的现金--470,000-
  取得借款收到的现金338,000,000118,374,779.1151,137,941.7656,061,209.31
  收到其他与筹资活动有关的现金43,042,716.3826,595,650.92--
  筹资活动现金流入小计381,042,716.38144,970,430.0351,607,941.7656,061,209.31
  偿还债务支付的现金60,277,0007,777,00065,554,00035,554,000
  分配股利、利润或偿付利息支付的现金18,177,935.963,070,471.1230,864,761.2228,882,828.53
  支付其他与筹资活动有关的现金32,458,014.3914,354,018.93132,089,151.13164,852,421.62
  筹资活动现金流出小计110,912,950.3525,201,490.05228,507,912.35229,289,250.15
  筹资活动产生的现金流量净额270,129,766.03119,768,939.98-176,899,970.59-173,228,040.84
四、汇率变动对现金及现金等价物的影响495,696.86657,329.264,980,565.433,173,928.92
五、现金及现金等价物净增加额-241,028,082.52-284,712,490.87225,781,892.82474,950,516.96
  加:期初现金及现金等价物余额582,186,378.02582,186,378.02356,404,485.2356,404,485.2
  期末现金及现金等价物余额341,158,295.5297,473,887.15582,186,378.02831,355,002.16
补充资料:
  净利润-6,408,271.22-51,461,755.73-
  资产减值准备26,054,288.41-36,433,808.91-
  固定资产和投资性房地产折旧95,647,658.86-172,942,863.33-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧95,647,658.86-172,942,863.33-
  无形资产摊销2,385,489.47-4,797,304.09-
  长期待摊费用摊销1,427,568.19-3,358,861.92-
  处置固定资产、无形资产和其他长期资产的损失-67,192.75--533,612.43-
  固定资产报废损失253,474.37-267,471.52-
  公允价值变动损失-812,583.52--3,817,511.65-
  财务费用5,977,442.41-11,714,414.2-
  投资损失-63,026.25--1,422,692.01-
  递延所得税-1,495,838.04-385,396.73-
  其中:递延所得税资产减少-1,598,485.01-301,125.09-
    递延所得税负债增加102,646.97-84,271.64-
  存货的减少-49,839,346.94--74,749,149.76-
  经营性应收项目的减少-218,683,753.19--168,428,628.62-
  经营性应付项目的增加-24,376,011.08--57,731,251.63-
  其他--8,618,011.28-
  现金的期末余额341,158,295.5-582,186,378.02-
  减:现金的期初余额582,186,378.02-356,404,485.2-
  现金及现金等价物的净增加额-241,028,082.52-225,781,892.82-
公告日期2025-08-282025-04-252025-04-252024-10-25
审计意见(境内)标准无保留意见
TOP↑